Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 May;31(5):543–545. doi: 10.1111/j.1365-2125.1991.tb05577.x

The comparative pharmacokinetics of acemetacin in young subjects and elderly patients.

R W Jones 1, A J Collins 1, L J Notarianni 1, E Sedman 1
PMCID: PMC1368473  PMID: 1888622

Abstract

Single and multiple dose pharmacokinetics of acemetacin in 10 young healthy subjects and 10 elderly patients with osteoarthritis were studied. Peak plasma concentrations of acemetacin and its metabolite, indomethacin, were found between 2.4 and 4 h after an oral dose of the drug. After dosing to steady state (7 days), the mean plasma elimination half-life for acemetacin was 1.1 h and 1.0 h, and for indomethacin 7.1 h and 7.2 h in the young and elderly groups respectively. Statistical analysis of tmax, AUC, plasma t1/2 and residual drug concentrations for acemetacin or indomethacin revealed no significant differences (P greater than 0.05) between young subjects and elderly patients after acute or chronic dosing. The results suggest that drug accumulation did not occur in the elderly subjects over the time period studied and that, on pharmacokinetic grounds, dose adjustment in the elderly is unlikely to be required.

Full text

PDF
545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jacobi H., Breier P., Dell H. D. Die antiphlogistische Wirkung von Acemetacin. Arzneimittelforschung. 1980;30(8A):1326–1347. [PubMed] [Google Scholar]
  2. Jacobi H., Dell H. D. Zur Pharmakodynamik von Acemetacin. Arzneimittelforschung. 1980;30(8A):1348–1362. [PubMed] [Google Scholar]
  3. Notarianni L. J., Collins A. J. Method for the determination of acemetacin, a non-steroidal anti-inflammatory drug, in plasma by high-performance liquid chromatography. J Chromatogr. 1987 Jan 23;413:305–308. doi: 10.1016/0378-4347(87)80244-x. [DOI] [PubMed] [Google Scholar]
  4. Rosowsky A., Solan V. C., Forsch R. A., Delcamp T. J., Baccanari D. P., Freisheim J. H. Methotrexate analogues. 30. Dihydrofolate reductase inhibition and in vitro tumor cell growth inhibition by N epsilon-(haloacetyl)-L-lysine and N delta-(haloacetyl)-L-ornithine analogues and an acivicin analogue of methotrexate. J Med Chem. 1987 Aug;30(8):1463–1469. doi: 10.1021/jm00391a031. [DOI] [PubMed] [Google Scholar]
  5. Walt R., Katschinski B., Logan R., Ashley J., Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986 Mar 1;1(8479):489–492. doi: 10.1016/s0140-6736(86)92940-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES